Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
September 13th, 2005
Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.
Ohio State University
National Cancer Institute
Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014
Local girl does good March 22nd, 2014
Surface Characteristics Influence Cellular Growth on Semiconductor Material March 12th, 2014
The "Tipping Point" February 12th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014
More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014
High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014